Does the METS-IR score predict visceral adiposity and incident type 2 diabetes in healthy and at-risk subjects?
METS-IR is a novel score that predicts visceral adiposity and incident type 2 diabetes, serving as a promising tool for insulin sensitivity screening.
METS-IR is a novel score to evaluate cardiometabolic risk in healthy and at-risk subjects and a promising tool for screening of insulin sensitivity.
Bello‐Chavolla et al. (2018) studied this question.